Funds holding Neumora Therapeutics Inc
ISIN US6409791000 · United States
- Fund holders
- 39
- Of which ETFs
- 11 28 other funds
- Value held
- 17.4M $
- Share of capital
- 3.9 % of 187.9M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,796,154 | 5.5M $ | 0.00 % | 1.49 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,001,813 | 2M $ | 0.00 % | 0.53 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 469,115 | 1.6M $ | 0.00 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 422,398 | 1.5M $ | 0.01 % | 0.22 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 421,430 | 821.8K $ | 0.01 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 314,119 | 775.9K $ | 0.10 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 225,000 | 438.8K $ | 0.36 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 221,105 | 546.1K $ | 0.00 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 196,001 | 484.1K $ | 0.02 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 186,984 | 461.9K $ | 0.04 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 173,358 | 605K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 171,100 | 597.1K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 127,090 | 443.5K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 117,013 | 228.2K $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 94,606 | 330.2K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 62,855 | 155.3K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 51,935 | 101.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 50,440 | 176K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 46,192 | 114.1K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 42,000 | 103.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 41,991 | 81.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 31,178 | 77K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 23,790 | 83K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 18,401 | 35.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 13,496 | 33.3K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 12,704 | 31.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 12,147 | 30K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9,348 | 32.6K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 8,006 | 15.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 7,715 | 26.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 7,610 | 18.8K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Victory Extended Market Index Fund Victory Portfolios III | 6,372 | 15.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 5,256 | 13K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 4,145 | 14.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3,060 | 7.6K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 3,032 | 5.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,957 | 5.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 1,022 | 3.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 481 | 1.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.36 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.15 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 0.10 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.04 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.04 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 0.03 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 39 | +10 | 7,403,419 | +14.8 % |
| 2026Q1 | 29 | -1 | 6,451,055 | -14.7 % |
| 2025Q4 | 30 | -24 | 7,565,025 | -23.4 % |
| 2025Q3 | 54 | -47 | 9,871,596 | -31.1 % |
| 2025Q2 | 101 | -22 | 14,317,515 | -34.9 % |
| 2025Q1 | 123 | -3 | 21,995,618 | +30.5 % |
| 2024Q4 | 126 | +13 | 16,859,011 | +46.8 % |
| 2024Q3 | 113 | +14 | 11,488,045 | +125.0 % |
| 2024Q2 | 99 | +31 | 5,106,129 | +209.5 % |
| 2024Q1 | 68 | +59 | 1,649,665 | +2,103.4 % |
| 2023Q4 | 9 | 74,868 |
Institutional managers
107 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Siren, L.L.C. | 8,497,822 | 16.6M $ | as of Mar 31, 2026 |
| SOFTBANK GROUP CORP. | 6,090,301 | 11.9M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 5,104,097 | 10M $ | as of Mar 31, 2026 |
| MIC Capital Management UK LLP | 4,460,700 | 8.7M $ | as of Mar 31, 2026 |
| FMR LLC | 3,498,658 | 6.8M $ | as of Mar 31, 2026 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | 6.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,754,854 | 5.4M $ | as of Mar 31, 2026 |
| ICONIQ Capital, LLC | 2,559,090 | 5M $ | as of Mar 31, 2026 |
| Lunate Capital Ltd | 2,124,143 | 4.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,054,316 | 4M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,036,692 | 4M $ | as of Mar 31, 2026 |
| JOHNSON & JOHNSON | 1,849,445 | 3.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,388,998 | 2.7M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,278,408 | 2.5M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,240,241 | 2.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,195,310 | 2.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,086,865 | 2.1M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | 2M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 818,156 | 1.6M $ | as of Mar 31, 2026 |
| TUDOR INVESTMENT CORP ET AL | 771,418 | 1.5M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 747,665 | 1.5M $ | as of Mar 31, 2026 |
| AlphaCore Capital LLC | 638,784 | 1.2M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 602,403 | 1.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 568,280 | 1.1M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 516,182 | 1M $ | as of Mar 31, 2026 |
Declared shareholders of Neumora Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ARCH Venture Fund VII, L.P. and 17 others | 18.70 % | 33,965,419 | as of Mar 30, 2026 · SCHEDULE 13D |
| Invus Public Equities, L.P. and 7 others | 4.70 % | 8,497,822 | as of Mar 31, 2026 · SCHEDULE 13G |
| K2 HealthVentures Equity Trust LLC and 2 others | 3.10 % | 5,790,453 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Neumora Therapeutics Inc". https://titelia.com/en/stocks/neumora-therapeutics-inc-US6409791000